CN1296078C - Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease - Google Patents
Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN1296078C CN1296078C CNB2005100752470A CN200510075247A CN1296078C CN 1296078 C CN1296078 C CN 1296078C CN B2005100752470 A CNB2005100752470 A CN B2005100752470A CN 200510075247 A CN200510075247 A CN 200510075247A CN 1296078 C CN1296078 C CN 1296078C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- roots
- cerebrovascular disease
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicinal preparation for treating cardiovascular/cerebrovascular diseases. The present invention is characterized in that the present invention is made from the following raw materials: manchurian catalpa bark, herba laminariae, red sage roots, angelica, rehmannia roots, peach kernels, flos carthami, aurantii, achyranthes roots, platycodon roots, red peony roots, earthworms, astragalus roots, chuanxiong rhizomes, licorice roots, bupleurum roots and borneol; the raw materials are respectively stoved, pulverized into powder sieved by a sieve with 100 to 150 meshes and uniformly mixed, then the madicinal powder is uniformly mixed with cooked honey according to the proportion by weight of 1 to 1 and manufactured into pills as finished products, and each pill weighs 12 grams. The present invention adopts medicines in the pharmacopoeia of traditional Chinese medicines, and provides an optimum prescription to realize the effects on activating the blood circulation, removing blood stasis, removing stasis, regulating the function of human body, removing thrombus, dredging blood passages, clearing heat, cooling blood and cleaning blood; the clinic application proves that the present invention has obvious effect, the cure rate for cardiovascular/cerebrovascular diseases reaches about 99%, the present invention can also be used for treating various diseases, such as hepatic adipose infiltration, liver cirrhosis, etc., and the curative effect is conspicuous.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, Chinese medicine preparation of particularly a kind of treatment cardiovascular and cerebrovascular disease of the blood stasis dispelling that purifies the blood and preparation method thereof.
Background technology
At present, cardiovascular and cerebrovascular disease is human No.1 killer, it also is a problem of all tackling key problems in countries in the world, because the each side factor of food and environment, cause hyperlipidemia, arteriosclerosis, deficiency myocardial blood supply and cerebral blood supply insufficiency, coronary heart disease, cerebral thrombosis, fatty liver etc., how this type of disease just can obtain correct treatment, have and be correct diagnosis and rational use of drug, most critical is with what medicine to suit the medicine to the illness, the real treatment cardiovascular and cerebrovascular disease of which kind of medicine energy is common people's joint research, a difficult problem inquiring into exploitation.
In view of this, in order to address the above problem, this creator through practical studies, and has the present invention to produce on for many years clinical practice and handed down from the older generations of the family basis eventually.
Summary of the invention
The present invention will provide a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, can dissolve cholesterol, triglyceride and reduce blood viscosity, thrombolytic, smooth blood, heat clearing away, removing heat from blood, purify the blood, its drug effect is remarkable, the cure rate height is the best good medicine of treatment cardiovascular and cerebrovascular disease.
The scheme that above-mentioned Chinese medicine preparation adopted is such:
A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is characterized in that: making the raw materials of effective components composition is by weight:
120～140 parts of 100～120 parts of Radix Salviae Miltiorrhizaes of 300～320 parts of Thallus Laminariae (Thallus Eckloniae)s of Cortex Juglandis mandshuricae
100～130 parts in 80～100 parts of Semen Persicaes of 80～100 parts of Radix Rehmanniae of Radix Angelicae Sinensis
50～70 parts of 50～70 parts of Radix Achyranthis Bidentataes of 80～100 parts of Fructus Aurantiis of Flos Carthami
20～40 parts of 50～70 parts of Pheretimas of 40～60 parts of Radix Paeoniae Rubra of Radix Platycodonis
20～50 parts in 70～100 portions of Radix Glycyrrhizaes of 200～220 parts of Rhizoma Chuanxiongs of the Radix Astragali
100～120 parts of 80～100 parts of Borneolum Syntheticums of Radix Bupleuri.
The raw materials in weight portion of this Chinese medicine preparation is:
130 parts of 110 parts of Radix Salviae Miltiorrhizaes of 310 parts of Thallus Laminariae (Thallus Eckloniae)s of Cortex Juglandis mandshuricae
115 parts in 90 parts of Semen Persicaes of 90 parts of Radix Rehmanniae of Radix Angelicae Sinensis
60 parts of 60 parts of Radix Achyranthis Bidentataes of 90 parts of Fructus Aurantiis of Flos Carthami
30 parts of 60 parts of Pheretimas of 50 parts of Radix Paeoniae Rubra of Radix Platycodonis
35 parts in 85 portions of Radix Glycyrrhizaes of 210 parts of Rhizoma Chuanxiongs of the Radix Astragali
110 parts of 90 parts of Borneolum Syntheticums of Radix Bupleuri.
Described medicament is a said dosage form on any pharmaceutics, and described medicament is a pill.
The preparation method of this medicine pill is: the weight portion proportioning by described raw material takes by weighing Cortex Juglandis mandshuricae, Thallus Laminariae (Thallus Eckloniae), Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, Semen Persicae, Flos Carthami, Fructus Aurantii, Radix Achyranthis Bidentatae, Radix Platycodonis, Radix Paeoniae Rubra, Pheretima, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae, Radix Bupleuri and Borneolum Syntheticum, oven dry is ground into 100～150 purpose powder respectively, and mix homogeneously, then that medicated powder end and ripe Mel is even by 1: 1 part by weight blending, make the finished product pill; The every ball weight of this pill is 11～13 grams.
The first morbidity that the present invention is directed to cardiovascular and cerebrovascular disease is because of being hyperlipidemia, cholesterol in the blood, deposits such as triglyceride, be deposited on the blood vessel wall, make vessel wall thickening, normal blood vessels can not absorb the desired nutritional composition, cause arteriosclerosis, when seriously arriving to a certain degree, deposit comes off, and forms angiemphraxis, cause cardiovascular and cerebrovascular disease, at first start with during treatment, have only and remove the cholesterol that exceeds standard from blood fat, triglyceride is reconciled blood viscosity, make blood fat reach normal value, again to spleen, stomach and hepatic and renal function are mediated, and suit the remedy to the case, thereby reach the optimum efficiency of thorough healing cardiovascular and cerebrovascular disease.
Advantage of the present invention is as follows:
1, the present invention has absorbed the medicine in the traditional Chinese medical science pharmacopeia, reaches to invigorate blood circulation, blood stasis dispelling, row's stasis of blood, regulate function of human body thrombolytic, smooth blood, heat clearing away, removing heat from blood, the curative effect that purifies the blood with optimum formula.
2, the clinical use of the present invention proves, instant effect reaches about 99% the cardiovascular and cerebrovascular disease cure rate, and every assay reaches normal index.
3, but also determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs of the present invention is suited the remedy to the case, and can treat multiple diseases such as fatty liver, liver cirrhosis, and is evident in efficacy.
The specific embodiment
This Chinese medicine preparation is the blood circulation promoting and blood stasis dispelling pill, and its optimum weight part proportion raw material is:
Cortex Juglandis mandshuricae 310 gram Thallus Laminariae (Thallus Eckloniae)s 110 gram Radix Salviae Miltiorrhizaes 130 grams
The Radix Angelicae Sinensis 90 gram Radix Rehmanniae 90 gram Semen Persicaes 115 grams
Flos Carthami 90 gram Fructus Aurantiis 60 gram Radix Achyranthis Bidentataes 60 grams
Radix Platycodonis 50 gram Radix Paeoniae Rubra 60 gram Pheretimas 30 grams
The Radix Astragali 210 gram Rhizoma Chuanxiongs 60 gram Radix Glycyrrhizaes 35 grams
Radix Bupleuri 90 gram Borneolum Syntheticums 110 grams
The preparation method of this medicine pill is: the weight portion proportioning by described raw material takes by weighing Cortex Juglandis mandshuricae, Thallus Laminariae (Thallus Eckloniae), Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, Semen Persicae, Flos Carthami, Fructus Aurantii, Radix Achyranthis Bidentatae, Radix Platycodonis, Radix Paeoniae Rubra, Pheretima, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae, Radix Bupleuri and Borneolum Syntheticum, oven dry is ground into 100～150 purpose powder respectively, and mix homogeneously, then that medicated powder end and ripe Mel is even by 1: 1 part by weight blending, make the finished product pill; The every ball weight of this pill is 12 grams.
Every day taken twice by this pill, each ball, and be 15 days a course of treatment.
Patients such as the clinical use of the present invention treatment cerebral thrombosis, coronary heart disease, hyperlipidemia, fatty liver are 216 people, and wherein 158 people have got well, and oneself disappears 54 people's diseases, recovering, and the 2 people own first meeting effect of taking medicine, case embodiment is as follows:
Case one:
The Wang: 52 years old, woman, cerebral thrombosis, the course of disease three months, check result cholesterol 10.5mmoi/L, triglyceride 5.2mmoi/L, blood viscosity 3.6mpa.s, CT reports 4mm * 5mm radiography bolt point, takes medicine 2 courses of treatment, finger, thigh tensible campaign, check rheology, cholesterol 3.5mmoi/L, triglyceride 0.9mmoi/L, blood viscosity 1.1mpa.s, CT examination radiography bolt point disappears.
Case two:
Zhu: man, 65 years old, cerebral thrombosis, the course of disease two days, cholesterol 9.5mmoi/L, triglyceride 4.3mmoi/L are checked in rheology, blood viscosity 4.0mpa.s, CT examination radiography bolt point 4mm * 4mm took medicine back 7 days, the trick tensible was walked down after 10 days, after one month, check rheology cholesterol 4.5mmoi/L, triglyceride 0.7mmoi/L, blood viscosity 0.95mpa.s, CT examination radiography bolt point disappears.
Clinical proof, the cerebral thrombus patient divides course of disease time length, and take effect 3～5 years 4 courses of treatment of generally taking medicine, and take effect 1～3 year 3 course of treatment, and 1 month～1 year person takes effect 2 courses of treatment, and neopathy took effect after 7 days; Hyperlipidemia, arteriosclerosis, fatty liver, liver cirrhosis, coronary heart disease were generally all thoroughly cured at one month.
In sum, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, suiting the remedy to the case, is the most basic general knowledge of our medical worker GPRS, and the difficult problem of developmental research cardiovascular and cerebrovascular disease is further to advance on forefathers' basis, and inquire into the restraint medicine that disease is found in research clinically in life neutralization, the cardiovascular and cerebrovascular disease patient is rehabilitated, and curative effect of the present invention has tangible lifting, the tool practicality, meet each important document of patent of invention, so propose application for a patent for invention in accordance with the law.
Claims (6)
1, a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is characterized in that: making the raw materials of effective components composition is by weight:
120～140 parts of 100～120 parts of Radix Salviae Miltiorrhizaes of 300～320 parts of Thallus Laminariae (Thallus Eckloniae)s of Cortex Juglandis mandshuricae
100～130 parts in 80～100 parts of Semen Persicaes of 80～100 parts of Radix Rehmanniae of Radix Angelicae Sinensis
50～70 parts of 50～70 parts of Radix Achyranthis Bidentataes of 80～100 parts of Fructus Aurantiis of Flos Carthami
20～40 parts of 50～70 parts of Pheretimas of 40～60 parts of Radix Paeoniae Rubra of Radix Platycodonis
20～50 parts in 70～100 portions of Radix Glycyrrhizaes of 200～220 parts of Rhizoma Chuanxiongs of the Radix Astragali
100～120 parts of 80～100 parts of Borneolum Syntheticums of Radix Bupleuri.
2, the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease according to claim 1 is characterized in that: it is to be made by following raw materials in weight portion:
130 parts of 110 parts of Radix Salviae Miltiorrhizaes of 310 parts of Thallus Laminariae (Thallus Eckloniae)s of Cortex Juglandis mandshuricae
115 parts in 90 parts of Semen Persicaes of 90 parts of Radix Rehmanniae of Radix Angelicae Sinensis
60 parts of 60 parts of Radix Achyranthis Bidentataes of 90 parts of Fructus Aurantiis of Flos Carthami
30 parts of 60 parts of Pheretimas of 50 parts of Radix Paeoniae Rubra of Radix Platycodonis
35 parts in 85 portions of Radix Glycyrrhizaes of 210 parts of Rhizoma Chuanxiongs of the Radix Astragali
110 parts of 90 parts of Borneolum Syntheticums of Radix Bupleuri.
3, the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease according to claim 1 and 2 is characterized in that: described medicament is a said dosage form on any pharmaceutics.
4, the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease according to claim 3 is characterized in that: described medicament is a pill.
5, the preparation method of the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease according to claim 4, it is characterized in that: the preparation method of this medicine pill is: the weight portion proportioning by described raw material takes by weighing Cortex Juglandis mandshuricae, Thallus Laminariae (Thallus Eckloniae), Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, Semen Persicae, Flos Carthami, Fructus Aurantii, Radix Achyranthis Bidentatae, Radix Platycodonis, Radix Paeoniae Rubra, Pheretima, the Radix Astragali, Rhizoma Chuanxiong, Radix Glycyrrhizae, Radix Bupleuri and Borneolum Syntheticum, oven dry is ground into 100～150 purpose powder respectively, and mix homogeneously, then that medicated powder end and ripe Mel is even by 1: 1 part by weight blending, make the finished product pill.
6, the preparation method of the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease according to claim 5 is characterized in that: the every ball weight of this pill is 11～13 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100752470A CN1296078C (en) | 2005-06-09 | 2005-06-09 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100752470A CN1296078C (en) | 2005-06-09 | 2005-06-09 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698823A CN1698823A (en) | 2005-11-23 |
| CN1296078C true CN1296078C (en) | 2007-01-24 |
Family
ID=35475177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100752470A Expired - Fee Related CN1296078C (en) | 2005-06-09 | 2005-06-09 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1296078C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972332A (en) * | 2010-10-29 | 2011-02-16 | 荣成市新技术应用研究所 | Traditional Chinese medicine for treating palpitations |
| CN104189314B (en) * | 2014-09-28 | 2017-09-15 | 张毅 | It is a kind of to treat the turbid pharmaceutical composition for checking card high fat of blood of phlegm |
| CN105535099A (en) * | 2016-01-02 | 2016-05-04 | 红河州吉昌生物科技有限公司 | Vasodistal biological medicine preparation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273122A (en) * | 1999-05-08 | 2000-11-15 | 吴景芳 | Synthetic orall liquid of red sage root |
-
2005
- 2005-06-09 CN CNB2005100752470A patent/CN1296078C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273122A (en) * | 1999-05-08 | 2000-11-15 | 吴景芳 | Synthetic orall liquid of red sage root |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1698823A (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1350852A (en) | Medicine for treating rheumatic or rheumatoid arthritis, osteoarthropathy and gout | |
| CN1365827A (en) | Exterior-applied medicine for treating osteopathy | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN1712054A (en) | Qinchuan Tongbi tablet | |
| CN1868535A (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
| CN1319590C (en) | Chinese medicinal preparation for treating hepatitis and preparation method thereof | |
| CN1296078C (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease | |
| CN1528386A (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN1840160A (en) | Powder for resisting hyperosteogeny | |
| CN1237443A (en) | Medicine for curing rheumatic heart disease | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN1223886A (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1270768C (en) | Medicine for treating cold disease | |
| CN1102399C (en) | Antilipemic blood circulation promoting xueluofu capsale | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1186056C (en) | medicine for treating hyperosteogeny | |
| CN1290551C (en) | A Chinese medicinal composition for invigorating kidney and strengthening bone | |
| CN1175890C (en) | Mastoproliferation treating medicine | |
| CN1219402A (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN1276771C (en) | Chinese materia medica preparation for treating spasm of eye and facial muscles, and preparing method | |
| CN1238013C (en) | Myocarditis treating Chinese medicine prepn | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN1159057C (en) | Medicine for treating hepatitis, and preparing process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070124 Termination date: 20130609 |